Akoya Biosciences Inc (AKYA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Akoya Biosciences Inc Stock (AKYA) Company Profile

Akoya Biosciences Inc

Healthcare (1176)

855.896.8401

100 CAMPUS DRIVE, MARLBOROUGH

Nächster Verdiensttermin

Neueste SEC-Einreichungen

AKYA's Discussions on Twitter

Vergleichen Sie AKYA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AKYA Akoya Biosciences Inc	2.51	124.43M	96.63M	-63.32M	-54.55M	-1.46
ISRG Intuitive Surgical Inc	588.50	209.89B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	227.21	68.23B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	91.65	45.33B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	237.18	34.84B	4.93B	1.25B	1.38B	8.47
WST West Pharmaceutical Services Inc	330.47	23.97B	2.88B	499.60M	321.60M	6.74

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-15	Herabstufung	Craig Hallum	Buy → Hold
2024-08-06	Herabstufung	BTIG Research	Buy → Neutral
2024-08-06	Herabstufung	JP Morgan	Overweight → Neutral
2024-08-06	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-21	Eingeleitet	Craig Hallum	Buy
2023-12-14	Eingeleitet	Guggenheim	Neutral
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-02-02	Eingeleitet	UBS	Buy
2022-11-03	Eingeleitet	CapitalOne	Overweight
2022-10-06	Eingeleitet	Stephens	Overweight
2022-06-22	Eingeleitet	BTIG Research	Buy
2022-01-06	Fortgesetzt	Piper Sandler	Overweight
2021-05-11	Eingeleitet	Canaccord Genuity	Buy
2021-05-11	Eingeleitet	JP Morgan	Overweight
2021-05-11	Eingeleitet	Morgan Stanley	Overweight
2021-05-11	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Akoya Biosciences Inc Aktie (AKYA) Neueste Nachrichten

Finanzdaten der Akoya Biosciences Inc-Aktie (AKYA)

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc Stock (AKYA) Company Profile

Vergleichen Sie AKYA mit anderen Aktien

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Akoya Biosciences Inc Aktie (AKYA) Neueste Nachrichten

Akoya Biosciences unveils strategic product roadmap - Yahoo Finance

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels - GlobeNewswire

Revolutionary Neurobiology Panels: Akoya's New Weapon Against Brain Disease Research - StockTitan

Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Increase in Short Interest - MarketBeat

Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire

Major Breakthrough: Akoya's Advanced Diagnostic Tech Gets Manufacturing Powerhouse Backing - StockTitan

Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN

Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - Yahoo Finance

Barclays PLC Buys 30,095 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of “Hold” from Analysts - Defense World

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jane Street Group LLC Decreases Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Akoya Biosciences (NASDAQ:AKYA) Cut to Hold at Canaccord Genuity Group - Defense World

Akoya Biosciences (NASDAQ:AKYA) Downgraded by Canaccord Genuity Group to Hold - MarketBeat

Major Player in the Spatial Biology Market Analysis by Type, - openPR

Akoya Biosciences to be acquired by Billerica research firm, create $220M business - Worcester Business Journal

Quanterix merging with Akoya to bolster biomarker portfolio - BioWorld Online

Quanterix announces acquisition of Akoya Biosciences By Investing.com - Investing.com Canada

Quanterix announces acquisition of Akoya Biosciences - Investing.com

Billerica diagnostics maker Quanterix to acquire Marlborough biotech - The Business Journals

Akoya Biosciences (NASDAQ: AKYA) Enters Merger Agreement with Quanterix Corporation - Defense World

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders - GlobeNewswire Inc.

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders - The Malaysian Reserve

$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerACCD, QTRX, AKYA, ESSA - Markets Insider

Quanterix Agrees to Buy Life Sciences Firm Akoya Biosciences - MSN

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc.AKYA - Business Wire

Quanterix Is Close to All-Stock Deal for Akoya Bioscience - MSN

Akoya climbs after merger deal with Quanterix - MSN

Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders - Business Wire

Quanterix to acquire Akoya Biosciences in an all-stock transaction - TipRanks

Akoya stock climbs after Quanterix merger deal (AKYA:NASDAQ) - Seeking Alpha

Major Player in the Spatial Proteomics Market 20252032 - openPR

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers - Business Wire

A Data-Based Look At Akoya Biosciences Inc (AKYA) - Stocks Register

State Street Corp Boosts Position in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Grows By 20.7% - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Analysts - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 20.7% in December - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by HighTower Advisors LLC - Defense World

Charles Schwab Investment Management Inc. Decreases Stake in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Akoya Biosciences updates director and officer indemnification agreements By Investing.com - Investing.com Canada

Akoya Biosciences updates director and officer indemnification agreements - Investing.com India

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 18.1% in November - Defense World

Market Cool On Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Pushing Shares 29% Lower - Simply Wall St

Finanzdaten der Akoya Biosciences Inc-Aktie (AKYA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie AKYA